The possible early role of endogenous glucocorticosteroids on the further ultrastructural development of the fetal rat lung epithelium was investigated in vitro using a potent antiglucocorticoid drug, RU 486. Lung primordia were explanted on day 13 of gestation and cultured for 4–6 days in the presence of fetal calf serum, with or without RU 486 in excess. The results obtained show that osmiophilic lamellar bodies specific for morphologically differentiated type-II cells did appear in a number of epithelial cells, even though the glucocorticosteroids possibly present in the culture medium, or transferred at explantation were antagonized by RU 486. The number of lamellar bodies stored in these pneumocytes was not different from that in controls. In contrast, their total surface area per cell profile was transiently decreased. Taken together the reported data strongly suggest that endogenous glucocorticosteroids are not necessary for the initiation of type-II cell differentiation.

Keywords:
RU 486, Rat fetus, Lung development, Type-II cell
This content is only available via PDF.
© 1990 S. Karger AG, Basel
1990
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.